These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9543550)

  • 1. Development of a microsatellite-based approach to co-segregation analysis of familial hypercholesterolaemic kindreds.
    Haddad L; Day LB; Attwood J; Povey S; Humphries SE; Day IN
    Ann Hum Genet; 1997 Nov; 61(Pt 6):497-506. PubMed ID: 9543550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of a novel splice mutation of low density lipoprotein receptor gene in a Chinese family with familial hypercholesterolemia].
    Lin J; Wang LY; Liu S; Pan XD; Du LP; Shi FR; Qin YW; Zhao Q; Guo HY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):14-8. PubMed ID: 14767901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel mutations of the LDL receptor gene associated with familial hypercholesterolemia in a Chinese family.
    Xie L; Gong QH; Xie ZG; Liang ZM; Hu ZM; Xia K; Xia JH; Yang YF
    Chin Med J (Engl); 2007 Oct; 120(19):1694-9. PubMed ID: 17935672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of Scotland.
    Lee WK; Haddad L; Macleod MJ; Dorrance AM; Wilson DJ; Gaffney D; Dominiczak MH; Packard CJ; Day IN; Humphries SE; Dominiczak AF
    J Med Genet; 1998 Jul; 35(7):573-8. PubMed ID: 9678702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects.
    Saint-Jore B; Varret M; Dachet C; Rabès JP; Devillers M; Erlich D; Blanchard P; Krempf M; Mathé D; Chanu B; Jacotot B; Farnier M; Bonaïti-Péllié C; Junien C; Boileau C
    Eur J Hum Genet; 2000 Aug; 8(8):621-30. PubMed ID: 10952765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid sizing of microsatellite alleles by gel electrophoresis on microfabricated channels: application to the D19S394 tetranucleotide repeat for cosegregation study of familial hypercholesterolemia.
    Cantàfora A; Blotta I; Bruzzese N; Calandra S; Bertolini S
    Electrophoresis; 2001 Oct; 22(18):4012-5. PubMed ID: 11700734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutation screening and functional analysis of low density lipoprotein receptor in a familial hypercholesterolemia family].
    Cheng XH; Zheng F; Zhou X; Xiong CL; Ding J; Chen YM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):55-8. PubMed ID: 18247305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of low density lipoprotein (LDL) receptor mutations, using restriction endonucleases, in familial hypercholesterolemia].
    Kerepesi M; Császár A; Földi J; Mesterházy J; Romics L
    Orv Hetil; 1997 Jan; 138(1):15-8. PubMed ID: 9026767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of low density lipoprotein receptor gene mutations and microsatellite haplotypes in Greek FH heterozygous children: six independent ancestors account for 60% of probands.
    Traeger-Synodinos J; Mavroidis N; Kanavakis E; Drogari E; Humphries SE; Day IN; Kattamis C; Matsaniotis N
    Hum Genet; 1998 Mar; 102(3):343-7. PubMed ID: 9544850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of three biallelic restriction fragment length polymorphisms versus a polymorphic dinucleotide tandem repeat polymorphism at the low-density-lipoprotein receptor gene locus for diagnosis of familial hypercholesterolemia.
    Weiss N; Gudnasson V; Ostwald P; Humphries S; Schuster H; Keller C
    Dis Markers; 1997 Nov; 13(3):141-51. PubMed ID: 9405927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
    Bourbon M; Rato Q;
    Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred.
    Haddad L; Day IN; Hunt S; Williams RR; Humphries SE; Hopkins PN
    J Lipid Res; 1999 Jun; 40(6):1113-22. PubMed ID: 10357843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel LDLR mutation, H190Y, in a Utah kindred with familial hypercholesterolemia.
    Hopkins PN; Wu LL; Stephenson SH; Xin Y; Katsumata H; Nobe Y; Nakajima T; Hirayama T; Emi M; Williams RR
    J Hum Genet; 1999; 44(6):364-7. PubMed ID: 10570905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
    Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing familial hypercholesterolaemia: the relevance of genetic testing.
    van Aalst-Cohen ES; Jansen AC; Tanck MW; Defesche JC; Trip MD; Lansberg PJ; Stalenhoef AF; Kastelein JJ
    Eur Heart J; 2006 Sep; 27(18):2240-6. PubMed ID: 16825289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of the atherogenic Lp(a) are elevated in FH.
    Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
    Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.